Lisata Therapeutics to Present at the Sequire Investor Summit in Puerto Rico

January 18, 2024

https://www.globenewswire.com/news-release/2024/01/18/2811546/0/en/Lisata-Therapeutics-to-Present-at-the-Sequire-Investor-Summit-in-Puerto-Rico.html

BASKING RIDGE, NJ, Jan. 18, 2024 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq:LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, Ph.D., President and Chief Executive Officer of Lisata, will deliver a company presentation at the upcoming Sequire Investor Summit being held January 23-25, 2024, at the Condado Vanderbilt Hotel in San Juan, Puerto Rico.

Read more at globenewswire.com

Related news for (LSTA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.